| 000 | 00999 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516165645.0 | ||
| 264 | 0 | _c20131203 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2013-07-510958 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMüller, Martin C | |
| 245 | 0 | 0 |
_aThe ne plus ultra for deep BCR-ABL sequencing? _h[electronic resource] |
| 260 |
_bBlood _cAug 2013 |
||
| 300 |
_a1536-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aDNA Mutational Analysis _xmethods |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 773 | 0 |
_tBlood _gvol. 122 _gno. 9 _gp. 1536-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2013-07-510958 _zAvailable from publisher's website |
| 999 |
_c23046009 _d23046009 |
||